7.14
price up icon4.39%   0.30
after-market アフターアワーズ: 7.14
loading

Day One Biopharmaceuticals Inc (DAWN) 最新ニュース

pulisher
12:03 PM

What is Day One Biopharmaceuticals Inc (DAWN) Stock Return on Shareholders’ Capital? - Sete News

12:03 PM
pulisher
04:34 AM

Finance Watch: No Big Post-ASCO Follow-On Frenzy, But Biotech Had A Good Week - insights.citeline.com

04:34 AM
pulisher
Apr 20, 2025

Geode Capital Management LLC Has $18.54 Million Holdings in Day One Biopharmaceuticals, Inc. (NASDAQ:DAWN) - Defense World

Apr 20, 2025
pulisher
Apr 17, 2025

BofA Adjusts Price Target on Day One Biopharmaceuticals to $21 From $24, Keeps Buy Rating - marketscreener.com

Apr 17, 2025
pulisher
Apr 11, 2025

Day One Biopharmaceuticals, Inc. (NASDAQ:DAWN) Shares Sold by Corebridge Financial Inc. - Defense World

Apr 11, 2025
pulisher
Apr 11, 2025

Vanguard Group Inc. Lowers Stock Holdings in Day One Biopharmaceuticals, Inc. (NASDAQ:DAWN) - Defense World

Apr 11, 2025
pulisher
Apr 10, 2025

Day One Biopharmaceuticals Pullback Is A Potential Buying Opportunity - Seeking Alpha

Apr 10, 2025
pulisher
Apr 10, 2025

Day One Biopharmaceuticals, Inc. (DAWN): Among Stocks Under $10 that Will Triple - MSN

Apr 10, 2025
pulisher
Apr 09, 2025

KLP Kapitalforvaltning AS Invests $150,000 in Day One Biopharmaceuticals, Inc. (NASDAQ:DAWN) - Defense World

Apr 09, 2025
pulisher
Apr 08, 2025

10 Stocks Under $10 that Will Triple - Insider Monkey

Apr 08, 2025
pulisher
Apr 07, 2025

HC Wainwright Analysts Decrease Earnings Estimates for DAWN - Defense World

Apr 07, 2025
pulisher
Apr 05, 2025

HC Wainwright Reaffirms Buy Rating for Day One Biopharmaceuticals (NASDAQ:DAWN) - Defense World

Apr 05, 2025
pulisher
Apr 03, 2025

H.C. Wainwright maintains Buy on Day One Biopharmaceuticals By Investing.com - Investing.com Canada

Apr 03, 2025
pulisher
Apr 02, 2025

Teacher Retirement System of Texas Buys 3,086 Shares of Day One Biopharmaceuticals, Inc. (NASDAQ:DAWN) - Defense World

Apr 02, 2025
pulisher
Apr 02, 2025

Day One Biopharmaceuticals, Inc. (NASDAQ:DAWN) Given Consensus Recommendation of “Buy” by Brokerages - Defense World

Apr 02, 2025
pulisher
Apr 02, 2025

Day One Biopharmaceuticals, Inc. (NASDAQ:DAWN) Given Consensus Recommendation of “Buy” by Analysts - The AM Reporter

Apr 02, 2025
pulisher
Mar 30, 2025

(DAWN) Investment Report - news.stocktradersdaily.com

Mar 30, 2025
pulisher
Mar 29, 2025

Swiss National Bank Grows Position in Day One Biopharmaceuticals, Inc. (NASDAQ:DAWN) - Defense World

Mar 29, 2025
pulisher
Mar 25, 2025

Charles Schwab Investment Management Inc. Grows Position in Day One Biopharmaceuticals, Inc. (NASDAQ:DAWN) - Defense World

Mar 25, 2025
pulisher
Mar 20, 2025

Day One Biopharmaceuticals, Inc. (NASDAQ:DAWN) Position Boosted by Bank of New York Mellon Corp - Defense World

Mar 20, 2025
pulisher
Mar 12, 2025

Buy Rating for Day One Biopharmaceuticals: Strong Financial Position and Strategic Growth Potential - TipRanks

Mar 12, 2025
pulisher
Mar 10, 2025

Does Wolfspeed Inc (NYSE: WOLF) Still Look Hot This Week? - stocksregister.com

Mar 10, 2025
pulisher
Mar 09, 2025

(DAWN) Proactive Strategies - Stock Traders Daily

Mar 09, 2025
pulisher
Mar 08, 2025

Day One Biopharmaceuticals, Inc. (NASDAQ:DAWN) Receives Average Recommendation of “Buy” from Brokerages - Defense World

Mar 08, 2025
pulisher
Mar 07, 2025

Rhumbline Advisers Has $957,000 Stake in Day One Biopharmaceuticals, Inc. (NASDAQ:DAWN) - Defense World

Mar 07, 2025
pulisher
Mar 07, 2025

Day One Biopharmaceuticals (NASDAQ:DAWN) Stock Price Down 5.5% on Analyst Downgrade - Defense World

Mar 07, 2025
pulisher
Mar 07, 2025

JPMorgan Chase & Co. Lowers Day One Biopharmaceuticals (NASDAQ:DAWN) Price Target to $34.00 - Defense World

Mar 07, 2025
pulisher
Mar 05, 2025

Day One Biopharmaceuticals, Inc. (DAWN): A Bull Case Theory - Insider Monkey

Mar 05, 2025
pulisher
Mar 03, 2025

Glioma Treatment Market Size Report 2034 | AnHeart Therapeutics - openPR.com

Mar 03, 2025
pulisher
Mar 01, 2025

HC Wainwright Issues Positive Estimate for DAWN Earnings - MarketBeat

Mar 01, 2025
pulisher
Mar 01, 2025

What is Wedbush's Forecast for DAWN Q1 Earnings? - MarketBeat

Mar 01, 2025
pulisher
Mar 01, 2025

Research Analysts Offer Predictions for DAWN Q1 Earnings - Defense World

Mar 01, 2025
pulisher
Mar 01, 2025

Needham & Company LLC Reaffirms Buy Rating for Day One Biopharmaceuticals (NASDAQ:DAWN) - MarketBeat

Mar 01, 2025
pulisher
Mar 01, 2025

What is Wedbush’s Forecast for DAWN Q1 Earnings? - Defense World

Mar 01, 2025
pulisher
Mar 01, 2025

Day One Biopharmaceuticals (NASDAQ:DAWN) Issues Quarterly Earnings Results, Misses Estimates By $0.34 EPS - MarketBeat

Mar 01, 2025
pulisher
Feb 28, 2025

Day One Biopharmaceuticals (NASDAQ:DAWN) Releases Earnings Results, Misses Expectations By $0.34 EPS - MarketBeat

Feb 28, 2025
pulisher
Feb 28, 2025

Day One Biopharmaceuticals (NASDAQ:DAWN) Reaches New 1-Year Low After Earnings Miss - MarketBeat

Feb 28, 2025
pulisher
Feb 28, 2025

Day One Biopharmaceuticals (NASDAQ:DAWN) Given New $36.00 Price Target at HC Wainwright - MarketBeat

Feb 28, 2025
pulisher
Feb 28, 2025

Day One Biopharmaceuticals, Inc. (DAWN) Reports Q4 Loss, Tops Revenue Estimates - MSN

Feb 28, 2025
pulisher
Feb 28, 2025

Wedbush Reiterates “Outperform” Rating for Day One Biopharmaceuticals (NASDAQ:DAWN) - Defense World

Feb 28, 2025
pulisher
Feb 28, 2025

Day One Biopharmaceuticals (NASDAQ:DAWN) Earns “Buy” Rating from Needham & Company LLC - Defense World

Feb 28, 2025
pulisher
Feb 28, 2025

Day One Biopharmaceuticals (NASDAQ:DAWN) Sets New 52-Week Low Following Weak Earnings - Defense World

Feb 28, 2025
pulisher
Feb 27, 2025

Day One Biopharma’s Earnings Call Highlights Growth and Challenges - TipRanks

Feb 27, 2025
pulisher
Feb 27, 2025

Day One Biopharmaceuticals, Inc.'s (NASDAQ:DAWN) Profit Outlook - Simply Wall St

Feb 27, 2025
pulisher
Feb 26, 2025

Promising Growth Potential for Day One Biopharmaceuticals Driven by Ojemda and FIREFLY-2 Trial - TipRanks

Feb 26, 2025
pulisher
Feb 26, 2025

Day One Biopharmaceuticals' (DAWN) Outperform Rating Reiterated at Wedbush - MarketBeat

Feb 26, 2025
pulisher
Feb 26, 2025

Day One Biopharmaceuticals, Inc. (NASDAQ:DAWN) Q4 2024 Earnings Call Transcript - Insider Monkey

Feb 26, 2025
pulisher
Feb 26, 2025

Earnings call transcript: Day One Biopharmaceuticals Q4 2024 results show growth - Investing.com Australia

Feb 26, 2025
pulisher
Feb 25, 2025

Earnings call transcript: Day One Biopharmaceuticals Q4 2024 results show growth By Investing.com - Investing.com South Africa

Feb 25, 2025
pulisher
Feb 25, 2025

Day One Biopharmaceuticals Reports Strong 2024 Results - TipRanks

Feb 25, 2025
pulisher
Feb 25, 2025

Adam Dubow Sells 4,646 Shares of Day One Biopharmaceuticals, Inc. (NASDAQ:DAWN) Stock - MarketBeat

Feb 25, 2025
pulisher
Feb 25, 2025

Day One Biopharmaceuticals Reports 2024 Financial Results - TipRanks

Feb 25, 2025
pulisher
Feb 25, 2025

Day One Biopharmaceuticals, Inc. SEC 10-K Report - TradingView

Feb 25, 2025
$20.07
price up icon 0.15%
$69.51
price down icon 4.32%
$32.19
price down icon 1.26%
$25.22
price up icon 2.48%
$101.81
price up icon 3.09%
biotechnology ONC
$229.22
price down icon 0.76%
大文字化:     |  ボリューム (24 時間):